175 related articles for article (PubMed ID: 25892103)
1. Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α.
Chan ST; Patel PR; Ransom TR; Henrich CJ; McKee TC; Goey AK; Cook KM; Figg WD; McMahon JB; Schnermann MJ; Gustafson KR
J Am Chem Soc; 2015 Apr; 137(16):5569-75. PubMed ID: 25892103
[TBL] [Abstract][Full Text] [Related]
2. Characterization and Synthesis of Eudistidine C, a Bioactive Marine Alkaloid with an Intriguing Molecular Scaffold.
Chan ST; Nani RR; Schauer EA; Martin GE; Williamson RT; Saurí J; Buevich AV; Schafer WA; Joyce LA; Goey AK; Figg WD; Ransom TT; Henrich CJ; McKee TC; Moser A; MacDonald SA; Khan S; McMahon JB; Schnermann MJ; Gustafson KR
J Org Chem; 2016 Nov; 81(22):10631-10640. PubMed ID: 27934476
[TBL] [Abstract][Full Text] [Related]
3. Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
Goey AK; Chau CH; Sissung TM; Cook KM; Venzon DJ; Castro A; Ransom TR; Henrich CJ; McKee TC; McMahon JB; Grkovic T; Cadelis MM; Copp BR; Gustafson KR; Figg WD
J Nat Prod; 2016 May; 79(5):1267-75. PubMed ID: 27140429
[TBL] [Abstract][Full Text] [Related]
4. Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.
Ruas JL; Berchner-Pfannschmidt U; Malik S; Gradin K; Fandrey J; Roeder RG; Pereira T; Poellinger L
J Biol Chem; 2010 Jan; 285(4):2601-9. PubMed ID: 19880525
[TBL] [Abstract][Full Text] [Related]
5. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
[TBL] [Abstract][Full Text] [Related]
6. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
7. Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1α and p300.
Yu Z; Liu Y; Zhu J; Han J; Tian X; Han W; Zhao L
J Biomol Struct Dyn; 2020 Jan; 38(1):1-12. PubMed ID: 30784357
[TBL] [Abstract][Full Text] [Related]
8. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies.
Kyle HF; Wickson KF; Stott J; Burslem GM; Breeze AL; Tiede C; Tomlinson DC; Warriner SL; Nelson A; Wilson AJ; Edwards TA
Mol Biosyst; 2015 Oct; 11(10):2738-49. PubMed ID: 26135796
[TBL] [Abstract][Full Text] [Related]
10. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
[TBL] [Abstract][Full Text] [Related]
11. Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha.
Cho H; Ahn DR; Park H; Yang EG
FEBS Lett; 2007 Apr; 581(8):1542-8. PubMed ID: 17382325
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule proteomimetic inhibitors of the HIF-1α-p300 protein-protein interaction.
Burslem GM; Kyle HF; Breeze AL; Edwards TA; Nelson A; Warriner SL; Wilson AJ
Chembiochem; 2014 May; 15(8):1083-7. PubMed ID: 24782431
[TBL] [Abstract][Full Text] [Related]
13. Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction.
Yang C; Wang W; Li GD; Zhong HJ; Dong ZZ; Wong CY; Kwong DW; Ma DL; Leung CH
Sci Rep; 2017 Feb; 7():42860. PubMed ID: 28225008
[TBL] [Abstract][Full Text] [Related]
14. A novel function of novobiocin: disrupting the interaction of HIF 1α and p300/CBP through direct binding to the HIF1α C-terminal activation domain.
Wu D; Zhang R; Zhao R; Chen G; Cai Y; Jin J
PLoS One; 2013; 8(5):e62014. PubMed ID: 23671581
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.
Freedman SJ; Sun ZY; Kung AL; France DS; Wagner G; Eck MJ
Nat Struct Biol; 2003 Jul; 10(7):504-12. PubMed ID: 12778114
[TBL] [Abstract][Full Text] [Related]
16. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
Dyson HJ; Wright PE
J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
[TBL] [Abstract][Full Text] [Related]
17. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
[TBL] [Abstract][Full Text] [Related]
18. Towards "bionic" proteins: replacement of continuous sequences from HIF-1α with proteomimetics to create functional p300 binding HIF-1α mimics.
Burslem GM; Kyle HF; Breeze AL; Edwards TA; Nelson A; Warriner SL; Wilson AJ
Chem Commun (Camb); 2016 Apr; 52(31):5421-4. PubMed ID: 27009828
[TBL] [Abstract][Full Text] [Related]
19. Roles of p300 and cyclic adenosine monophosphate response element binding protein in high glucose-induced hypoxia-inducible factor 1α inactivation under hypoxic conditions.
Ding L; Yang M; Zhao T; Lv G
J Diabetes Investig; 2017 May; 8(3):277-285. PubMed ID: 27808477
[TBL] [Abstract][Full Text] [Related]
20. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression.
Kasper LH; Boussouar F; Boyd K; Xu W; Biesen M; Rehg J; Baudino TA; Cleveland JL; Brindle PK
EMBO J; 2005 Nov; 24(22):3846-58. PubMed ID: 16237459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
